Allergic rhinitis decisions — 2025

The Board granted a 70 percent rating for posttraumatic stress disorder and unspecified depressive disorder effective March 3, 2021, and a 30 percent rating for gastroesophageal reflux disease from January 26, 2022.

The Board denied the veteran's claims for a higher rating for PTSD and service connection for sinusitis and rhinitis.

The veteran withdrew all pending appeals before the Board promulgated a decision.

The Board denied increased ratings for PTSD, interstitial lung disease, allergic rhinitis, and chronic sinusitis. The claims for service connection were remanded.

The Board denied the Veteran's appeal for an initial rating greater than 10 percent for allergic rhinitis, as there was no evidence of polyps and the criteria for a higher rating were not met.

The Board granted service connection for asthma and rhinitis, both presumptively linked to exposure to fine particulate matter during the Veteran's service in the Southwest Asia theatre of operations.

The Board denied the veteran's claims for a total disability based on individual unemployability, special monthly compensation based on the need for regular aid and attendance, SMC based on housebound status, and service connection for vertigo.

The Board denied a compensable rating for allergic rhinitis and service connection for traumatic brain injury (TBI) based on the evidence of record.

The Board remands the claims for service connection for rhinitis, sinusitis, and a respiratory disability to obtain additional medical evidence.

The appeal for service connection for tinnitus was denied an earlier effective date, and the appeal for allergic rhinitis was dismissed.

The Board remands the claim for a compensable disability rating for allergic rhinitis with acute sinusitis to correct an error by the AOJ in failing to provide proper notice of the Veteran's right to a hearing on a Supplemental claim.

The Board dismissed the claims for earlier effective dates for entitlement to service connection for left knee patellofemoral pain syndrome with tendinitis, lumbar spondylolisthesis and spondylosis, left lower extremity (LLE) radiculopathy, and allergic rhinitis.

The Board granted service connection for right lower extremity radiculopathy as secondary to the service-connected disability of wedge compression fracture at L1 with end plate spurring, degenerative disc disease, and annular tear at the L5-S1. The claim for service connection for rhinitis was denied.

The Board granted service connection for chronic fatigue syndrome and an initial 70 percent rating for posttraumatic stress disorder (PTSD), while denying service connection for fibromyalgia, respiratory insufficiency, tension headaches, TMJ/TMD, right knee disability, left knee disability, bilateral hearing loss, and a scar associated with the right knee.

The Veteran's service-connected disabilities preclude him from obtaining or maintaining substantial, gainful employment, and a total disability rating based on individual unemployability due to service-connected disabilities (TDIU) is granted.

The Board denied the veteran's claims for an initial compensable evaluation for chronic rhinitis and chronic sinusitis, and dismissed his appeal for service connection for obstructive sleep apnea (OSA).

The Board granted service connection for tinnitus but denied it for bilateral hearing loss, chronic sinusitis, chronic fatigue syndrome, and chronic headaches. The initial ratings for generalized anxiety disorder with alcohol use disorder and allergic rhinitis were also denied.

The Board denied service connection for left knee disability, right knee disability, allergic rhinitis, and a psychiatric disorder as the evidence did not support a finding that these conditions were related to the Veteran's active duty service.

The Board granted service connection for non-allergic rhinitis, lung nodules, prostate cancer, and diabetes mellitus due to herbicide agent exposure. The claims for an ocular disorder and kidney disease were denied.

The Board granted service connection for asthma, chronic sinusitis, bronchitis, and allergic rhinitis based on the evidence of record.